TNFSF4 Chimeric Monoclonal Antibody

---

References

• Zubairi S, Sanos SL, Hill S, Kaye PM. Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani Eur J Immunol. 2004 May;34(5):1433-40.
• Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients Blood. 2003 May 1;101(9):3741-8.
• Meyer L, López T, Espinosa R, Arias CF, Vollmers C, DuBois RM. A simplified workflow for monoclonal antibody sequencing PLoS One. 2019 Jun 24;14(6):e0218717.
• Alejandra WP, Miriam Irene JP, Fabio Antonio GS, Patricia RR, Elizabeth TA, Aleman-Aguilar JP, Rebeca GV. Production of monoclonal antibodies for therapeutic purposes: A review Int Immunopharmacol. 2023 Jul;120:110376.
• Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shepard HM. Humanization of an anti-p185HER2 antibody for human cancer therapy Proc Natl Acad Sci U S A. 1992 May 15;89(10):4285-9.
• Ametrano A, Coscia MR. Production of a Chimeric Mouse-Fish Monoclonal Antibody by the CRISPR/Cas9 Technology Methods Mol Biol. 2022;2498:337-350.
• Mi L, Li W, Li M, Chen T, Wang M, Sun L, Chen Z. Immunogenicity screening assay development for a novel human-mouse chimeric anti-CD147 monoclonal antibody (Metuzumab) J Immunol Methods. 2016 Jun;433:38-43.
• Kaliyaperumal R, Ranganathan S, Krishnamoorthy M, Mohan VK, Balaraman S, Rajapandian G, Sathiyasundar R, Ravindran S. Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery Recent Adv Drug Deliv Formul. 2023;17(4):264-285.
• Hashimoto Y, Hata T, Tada M, Iida M, Watari A, Okada Y, Doi T, Kuniyasu H, Yagi K, Kondoh M. Safety evaluation of a human chimeric monoclonal antibody that recognizes the extracellular loop domain of claudin-2 Eur J Pharm Sci. 2018 May 30;117:161-167.